Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 May 13;11(10):1639. doi: 10.3390/cells11101639

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Low levels of intermediate monocytes associate with improved progression-free survival. Kaplan–Meier curves of progression-free survival (PFS; left) and overall survival (OS) from baseline (right) according to the levels of indicated monocyte subpopulation in all MBC patients. (A) CD14⁺⁺CD16⁻ classical monocytes. (B) CD14⁺⁺CD16^+/++ intermediate monocytes. (C) CD14⁺CD16⁺⁺ non-classical monocytes. (D) ratio of % CD16⁺ monocyte populations/% CD16⁻ monocyte populations. N = 27 for all subpopulations. Statistics by log-rank test, p-values < 0.05 highlighted in bold.